A new study led by Columbia’s Mathew Maurer found that tafamidis reduced deaths from transthyretin amyloid cardiomyopathy, a type of heart failure.
Columbia researchers are enrolling women in a new study to learn if inadequate sleep increases risk of heart disease.
A study revealing new structural details of an intracellular channel that controls muscle contraction may lead to new drugs for heart and muscle diseases.
A type of heart failure caused by a build-up of amyloid can be accurately diagnosed and prognosticated with an imaging technique, eliminating the need for a biopsy.
An international observational study led by Columbia University researchers has uncovered widespread differences in the treatment of patients with common chronic diseases, including type 2 diabetes, hypertension, and depression.
Wearing a 24-hour monitoring device may help identify African-Americans who have masked hypertension.